Expands visibility across AI assistants, conversational search and AI discovery platforms Targets institutional investors, hedge funds, family offices, bankers and retail investors Highlights LiveOne trades at ~.7x revenue versus public comps at 3.0x+ undervaluing its PodcastOne ownership, AI initiatives and ongoing share repurchase programLOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment and technology platform, and its subsidiary, PodcastOne (Nasdaq: PODC) today announced an extended partnership with Gotavi designed to accelerate AI-driven engagement, expand institutional and retail shareholder awareness, and strengthen visibility across rapidly emerging AI-powered discovery ecosystems. “Artificial intelligence is rapidly transforming how audiences discover,...

The Global Fitness Franchise Platform Introduces a Structured Program Designed for Current, Transitioning, and Former Athletes AUSTIN, TX, May 11, 2026 (GLOBE NEWSWIRE) — FIT House of Brands, a global leader in fitness franchising, today announced the launch of its Athlete Ownership Initiative – a strategic program designed to help current, transitioning, and semi-retired athletes build sustainable businesses through fitness franchise ownership. As more athletes seek long-term financial security and identity beyond their playing careers, the Athlete Ownership Initiative provides a clear and structured pathway to entrepreneurship, leveraging the discipline, leadership, and performance mindset developed through sport. “Too often, athletes are offered short-term opportunities instead of long-term ownership,” said Tom Dowd, Chief Executive...

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 11, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the May 11, 2026 French legal announcements bulletin n°56 (Bulletin des Annonces Légales Obligatoires – BALO) the notice of the Combined Shareholders Meeting, which will be held on June 15, 2026, at 10:00 am (CET), at the Faculty of Pharmaceutical Sciences in Lille, located at Parc Eurasanté, 3 rue du Professeur Laguesse, 59000 Lille, France. All documentation regarding this Combined Shareholders’ Meeting will be available to shareholders in accordance with existing regulations on the Company’s website, in the Financials section under the Combined Shareholders...

FOREST CITY, Iowa, May 11, 2026 (GLOBE NEWSWIRE) — Winnebago® announced the launch of ARKA™, a new off-grid, all-season adventure truck, expanding its rugged RV portfolio for travelers who go farther and stay longer. Joining Winnebago’s Backcountry Series alongside Revel® and EKKO™, ARKA is designed to be tough, approachable and reliable, prioritizing durability and real-world performance. Bridging off-road capability and premium RV comfort, ARKA is a self-reliant basecamp engineered for the demands of real backcountry travel. Purpose-driven design, all-season durability and extended off-grid independence are backed by Winnebago’s OEM-level testing, including durability simulations replicating over 100,000 miles of road and trail input. This approach focuses on doing the right things exceptionally well, allowing owners...

Exercised options total USD 97 million, covering manufacturing of bulk vaccine and supply of freeze-dried vaccines. Company upgrades full-year financial guidanceCOPENHAGEN, Denmark, May 11, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Center for the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has exercised additional options valued at USD 97 million under the existing contract to supply a freeze-dried formulation of JYNNEOS® smallpox vaccine. The options will support the manufacturing and supply of freeze-dried JYNNEOS, including manufacturing of additional bulk vaccine necessary for fulfilling the contract, as well as supplemental payments, triggered by the demonstration...

In accordance with the regulations relating to share buybacks, Technip Energies (PARIS:TE) declares the following purchases of its own shares from May 4, 2026, to May 8, 2026. These transactions were carried out as part of the buyback program with a discretionary mandate carried out by an investment services provider making decisions relating to the acquisition of Technip Energies shares independently.Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code)TECHNIP ENERGIES NV 724500FLODI49NSCIP70 5/4/2026 NL0014559478 20,523 38.9799 XPARTECHNIP ENERGIES NV 724500FLODI49NSCIP70 5/5/2026 NL0014559478 14,296 38.3963 XPARTECHNIP ENERGIES NV 724500FLODI49NSCIP70 5/6/2026 NL0014559478 3,800 39.4660 XPARTECHNIP...

As previously announced, the Annual General Meeting of Shareholders (the “Meeting”) of AUGA group, AB under restrutcturing (legal entity code 126264360, registered office at Konstitucijos ave. 21C, Vilnius, the “Company”) is being convened on 22 May 2026 at the initiative and by decision of the Board of the Company. By this notice, the Company announces the proposed draft resolution for agenda item 5 and provides general voting ballot. Agenda of the Meeting:Presentation of the Company’s consolidated management report for 2025 and the independent auditor’s report, except for the part of the Company’s remuneration report; Approval of the Company’s remuneration report for 2025 as part of the Company’s consolidated management report for 2025; Approval of the Company’s consolidated annual financial statements for 2025; Approval of the allocation...

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global player in pharmaceutical compounding, today held its Annual and Extraordinary General Meeting of Shareholders. All resolutions proposed by the Board of Directors were approved. Resolutions approved at the General Meetings The Annual General Meeting approved the annual accounts and the other annual documents for the 2025 financial year, including the distribution of a gross dividend of EUR 0.40 per share. In addition, the revised remuneration policy was adopted. Furthermore, the meeting confirmed the final appointments of Ms Ira Bindra as independent director and Mr Philipp Klecka as non-executive director. Both had previously been appointed by...